Korman Tyler Paz 4

What Happened

• Korman Tyler Paz, Chief Scientific Officer of ExoZymes Inc. (EXOZ), sold a total of 1,500 shares in two open‑market transactions. On 2026-04-08 he sold 750 shares at $10.04 ($7,530) and on 2026-04-09 he sold 750 shares at $10.53 ($7,894), for combined proceeds of approximately $15,424. These were outright sales (transaction code S), not purchases or option exercises.

Key Details

• Transactions: Apr 8, 2026 — 750 shares @ $10.04 ($7,530); Apr 9, 2026 — 750 shares @ $10.53 ($7,894)
• Total shares sold: 1,500; total proceeds: ~$15,424
• Transaction type: Open market sales (code S)
• Shares owned after transaction: Not specified in the excerpt provided
• Filing: Form 4 filed Apr 10, 2026 (appears timely based on transaction dates)
• No 10b5-1 plan, tax‑withholding, or other footnotes were reported in the details supplied

Context

• Sales by insiders can be routine (diversification, taxes, personal reasons) and do not by themselves indicate company performance or insider sentiment. The amount here (~$15.4K) is relatively modest compared with typical executive trades.